Powered by: Motilal Oswal
24/08/2023 11:06:32 AM | Source: Accord Fintech
Auro Laboratories zooms on getting nod for capacity expansion
News By Tags | #642 #572

Auro Laboratories is currently trading at Rs. 93.57, up by 10.87 points or 13.14% from its previous closing of Rs. 82.70 on the BSE.

The scrip opened at Rs. 84.79 and has touched a high and low of Rs. 94.75 and Rs. 84.79 respectively. So far 111325 shares were traded on the counter.

The BSE group 'X' stock of face value Rs. 10 has touched a 52 week high of Rs. 99.00 on 19-May-2023 and a 52 week low of Rs. 52.50 on 31-Mar-2023.

Last one week high and low of the scrip stood at Rs. 94.75 and Rs. 78.75 respectively. The current market cap of the company is Rs. 56.10 crore.

The promoters holding in the company stood at 52.09%, while Institutions and Non-Institutions held 0.01% and 47.90% respectively.

Auro Laboratories has received approval for a capacity expansion in the existing unit of the Company. The proposed Capacity is expected to be added by March 31, 2024 and investment required for the said capacity expansion is around Rs 40 crore. Mode of Financing is Internal Accruals and Term Loan from Bank. The Board of Directors of the Company, at their meeting held on August 23, 2023, has approved the same. 

Auro Laboratories incorporated in 1989 is engaged in business of manufacturing active pharmaceutical ingredients (API's), intermediates and generic formulations.

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here